We increasingly use regenerative medicine methods in combination with traditional surgical procedures towards restoring the natural balance (homeostasis) in joints and tissues as quickly as possible after surgery. The scientific background that we rely on in PRP (platelet-rich plasma) therapy involves placing as many bioactive agents as possible into the operation site:

  • perioperative and postoperative care of wound/tissue regeneration and pain therapy with promotion of healing results in functional and structural development
  • extended arthrosis treatment by means of intraosseous joint measures (treatment in the bones near the joint in the event of damage to the cartilage-bone supply and the resulting disturbance of the joint function and cause of pain) as an outpatient surgical intervention

PRGF (plasma rich in growth factors) contains many growth factors, cytokines and other proteins along with fibrinogen, prothrombin, and fibronectin. We use three different formulations of the original PRP Endoret. Activation using calcium chloride results in PRP in fluid, gel, or fibrin membrane form. PRGF Endoret aims at achieving the following effects:

  • Supporting and speeding up the body’s natural inflammatory defence response for primary tissue repair
  • Preventing excessive scarring
  • Providing bioactive agents in excess
  • PRP reduces postoperative pain after any type of surgical operation

These processes are initiated on activation using calcium chloride.